In addition to protecting the confidentiality of any material received, reviewers must record their conflict(s), if any, and abstain from scoring the abstract(s) if any conflict of interest arises.
Abstracts will be peer-reviewed, according to category. All abstracts are entered into the ASBMR Abstracts Database. The information from each abstract is captured within different fields in the Database. To ensure absolute impartiality in the reviewing process, a “blinded” copy of each abstract will be generated for the review process. “Blinded” copies will not include author or institutional field information, but rather the title and body of your abstract only. The abstract reviewers will score abstracts based on the merit of the submission only.
Program Assignment Notification
By the end of June 2025, you will receive an e-mail notifying you of your program assignment. It is the responsibility of the presenting author/submitter to notify the other authors of the program assignment. Please note: Program Assignment Letters are e-mailed to the presenting author and the email address used during submission. Please ensure the presenting author will have access to the email address used in the submission when notifications are sent by ASBMR staff. If the email address has changed, please reach out to abstracts@asbmr.org.
Withdrawal
All requests to withdraw an abstract must be received in writing at the ASBMR Business Office. Abstracts may not be withdrawn after July 23, 2025, unless an acceptable explanation is received. An acceptable reason for withdrawal is the inability to reproduce data in the abstract. The abstract submission fee is non-refundable.
Copyright
Abstracts submitted to the ASBMR 2025 Annual Meeting are copyrighted by the American Society for Bone and Mineral Research and published in the Journal of Bone and Mineral Research (JBMR®). Reproduction, distribution or transmission of the abstracts, in whole or in part, by any means, is prohibited without the express written permission of the American Society for Bone and Mineral Research. Please see list of retained author rights in the Copyright Transfer Agreement section above.
Disclaimer
All authored abstracts, findings, conclusions, recommendations or oral presentations are those of the author(s) and/or speaker(s) and do not reflect the views of the American Society for Bone and Mineral Research or imply any endorsement. No responsibility is assumed, and responsibility is hereby disclaimed, by the American Society for Bone and Mineral Research for any injury and/or damage to persons or property as a matter of products’ liability, negligence or otherwise, or from any use or operation of methods, products, instructions or ideas presented in the abstracts or at the ASBMR 2025 Annual Meeting. Independent verification of diagnosis and drug dosages should be made. Discussions, views and recommendations regarding medical procedures, choice of drugs and drug dosages are the responsibility of the authors and presenters.
Embargo
The ASBMR is sensitive to issues of commercial confidentiality and relevant aspects of the U.S. Securities and Exchange (SEC) regulations. Therefore, the ASBMR reminds all readers that everyone must adhere to the SEC regulations and treat all scientific information as confidential until the embargo has been lifted. The embargo lifts at the start time of the session in which the presentation is being made. Any reader of, or listener to, ASBMR 2025 Annual Meeting content may be viewed as an “insider” by the SEC due to knowledge of information included in abstracts, particularly clinical trial abstracts. SEC regulations may call for criminal penalties for using such information.
Abstracts submitted to the ASBMR 2025 Annual Meeting are embargoed – that is, unavailable for public release in written, oral or electronic communications – until the start time of the presentation at the ASBMR Annual Meeting. Public release includes presentation of data by the presenting author, colleagues, or others (1) in writing, on the internet or in other electronic formats, (2) orally in interviews or at other sessions/meetings that are not part of this official ASBMR program and/or take place before the embargo is lifted, (3) at the ASBMR 2025 Annual Meeting before the embargo is lifted and (4) in traditional text publications (e.g., journals, newspapers, newsletters) that will be published before the embargo is lifted. In addition, ASBMR reminds presenters and attendees that other organizations’ and entities’ embargoes should be honored. Any issues that arise in relation to this policy should be promptly reported to the ASBMR Executive Director in writing. This is a longstanding ASBMR policy that will be enforced.